ICHOM Patient Centered Outcomes Measure Set for Breast Cancer
1.0.0 - trial-use International flag

This page is part of the ICHOM FHIR Implementation Guide: Breast Cancer (v1.0.0: STU 1) based on FHIR R4. This is the current published version. For a full list of available versions, see the Directory of published versions

: Type of complication CodeSystem - JSON Representation

Page standards status: Trial-use Maturity Level: 2

Raw json | Download


{
  "resourceType" : "CodeSystem",
  "id" : "ComplicationTypeCodeSystem",
  "text" : {
    "status" : "generated",
    "div" : "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p>This code system <code>http://hl7.org/fhir/uv/ichom-breast-cancer/CodeSystem/ComplicationTypeCodeSystem</code> defines the following codes:</p><table class=\"codes\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td></tr><tr><td style=\"white-space:nowrap\">partial-loss<a name=\"ComplicationTypeCodeSystem-partial-loss\"> </a></td><td>Partial autologous graft loss</td></tr><tr><td style=\"white-space:nowrap\">total-loss<a name=\"ComplicationTypeCodeSystem-total-loss\"> </a></td><td>Total autologous graft loss</td></tr><tr><td style=\"white-space:nowrap\">delay-wound<a name=\"ComplicationTypeCodeSystem-delay-wound\"> </a></td><td>Delay wound healing/dehiscence</td></tr><tr><td style=\"white-space:nowrap\">immune-toxicity<a name=\"ComplicationTypeCodeSystem-immune-toxicity\"> </a></td><td>Immune related toxicity</td></tr></table></div>"
  },
  "extension" : [
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm",
      "valueInteger" : 2,
      "_valueInteger" : {
        "extension" : [
          {
            "url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-conformance-derivedFrom",
            "valueCanonical" : "http://hl7.org/fhir/uv/ichom-breast-cancer/ImplementationGuide/hl7.fhir.uv.ichom-breast-cancer"
          }
        ]
      }
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status",
      "valueCode" : "trial-use",
      "_valueCode" : {
        "extension" : [
          {
            "url" : "http://hl7.org/fhir/StructureDefinition/structuredefinition-conformance-derivedFrom",
            "valueCanonical" : "http://hl7.org/fhir/uv/ichom-breast-cancer/ImplementationGuide/hl7.fhir.uv.ichom-breast-cancer"
          }
        ]
      }
    }
  ],
  "url" : "http://hl7.org/fhir/uv/ichom-breast-cancer/CodeSystem/ComplicationTypeCodeSystem",
  "version" : "1.0.0",
  "name" : "ComplicationTypeCodeSystem",
  "title" : "Type of complication CodeSystem",
  "status" : "active",
  "experimental" : false,
  "date" : "2023-08-21T17:29:06+00:00",
  "publisher" : "HL7 International - Clinical Interoperability Council Group",
  "contact" : [
    {
      "name" : "HL7 International - Clinical Interoperability Council Group",
      "telecom" : [
        {
          "system" : "url",
          "value" : "http://www.hl7.org/Special/committees/cic"
        }
      ]
    }
  ],
  "description" : "Codes indicating the type of a complication experienced by the breast cancer patient",
  "jurisdiction" : [
    {
      "coding" : [
        {
          "system" : "http://unstats.un.org/unsd/methods/m49/m49.htm",
          "code" : "001",
          "display" : "World"
        }
      ]
    }
  ],
  "caseSensitive" : true,
  "content" : "complete",
  "count" : 4,
  "concept" : [
    {
      "code" : "partial-loss",
      "display" : "Partial autologous graft loss"
    },
    {
      "code" : "total-loss",
      "display" : "Total autologous graft loss"
    },
    {
      "code" : "delay-wound",
      "display" : "Delay wound healing/dehiscence"
    },
    {
      "code" : "immune-toxicity",
      "display" : "Immune related toxicity"
    }
  ]
}